- Wellcome Clinical Research Career Development Fellow
- Honorary Consultant Psychiatrist
My research focuses on trying to develop better ways of helping people with psychotic disorders like schizophrenia. All current drug treatments work the same way, and while these can help with certain aspects of the disorder, they are ineffective for the cognitive aspects (e.g. problems with memory, planning, and attention) that account for much of the disability associated with the illness.
I undertake studies testing new treatments in both humans and animal models of the illness with the aim of improving cognitive symptoms. In these studies I use techniques such as positron emission tomography and functional MRI to better understand the mechanisms underlying both symptoms and effects of treatment.
I undertook a Chemistry BSc before studying medicine. I then undertook NIHR academic foundation training and clinical fellowship, before completing a Wellcome Clinical PhD fellowship and NIHR academic clinical lectureship during my psychiatric training. My work is now funded by a Wellcome Clinical Research Career Development Fellowship. In addition to colleagues at Oxford I also collaborate closely with researchers at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London.
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis
McCutcheon R., (2023), Lancet Psychiatry
Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development.
Pillinger T. et al, (2023), Lancet Psychiatry, 10, 860 - 876
Clinical quandaries in psychotic disorders: the road is long, with many a winding turn.
Jauhar S. and McCutcheon RA., (2023), J Psychopharmacol
Does slow and steady win the race? Rates of antipsychotic discontinuation, antipsychotic dose, and risk of psychotic relapse
McCutcheon R., (2023), Schizophrenia Bulletin
How to classify antipsychotics: time to ditch dichotomies?
McCutcheon R., (2023), British Journal of Psychiatry